» Articles » PMID: 11804672

The Role of Hepatitis B Virus-specific Memory CD8 T Cells in the Control of Viral Replication

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2002 Jan 24
PMID 11804672
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The aim of this study is to clarify the differences of host immune responses between acute self-limited and chronic persistent hepatitis B virus (HBV) infections by quantitative and qualitative analysis of HLA-A*2402-restricted HBV-specific CD8+ T cells.

Methods: HBV-specific CD8+ T cells in peripheral blood mononuclear cells (PBMCs) from patients infected with HBV were analyzed by flow cytometry using two HLA-A*2402-HBV peptide tetrameric complexes.

Results: High numbers of HBV-specific CD8+ T cells were detected in acute phase PBMCs from most individuals with acute HBV infection while the number of these cells was greatly reduced in recovery phase PBMCs. HBV-specific CD8+ T cells were not detected in PBMCs from individuals with chronic HBV infection except for one patient during acute exacerbation. HBV-specific CD8+ T cells were induced by in vitro peptide stimulation in PBMCs from chronic HBV carriers with a low level of serum HBV-DNA but not from those with a high level of serum HBV-DNA. CD28CD45RA phenotype analysis showed that HBV-specific CD8+ T cells in acute phase PBMCs predominantly express a memory T cell phenotype.

Conclusions: HBV-specific memory CD8+ T cells may play a crucial role in complete clearance of HBV from patients with acute HBV hepatitis.

Citing Articles

Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics.

Hu J, Huang A Virol Sin. 2023; 39(1):9-23.

PMID: 38110037 PMC: 10877440. DOI: 10.1016/j.virs.2023.12.005.


TIGIT marks exhausted T cells and serves as a target for immune restoration in patients with chronic HBV infection.

Wei Y, Fan J, Shan M, Yin D, Wang L, Ye W Am J Transl Res. 2022; 14(2):942-954.

PMID: 35273697 PMC: 8902551.


A quantitative systems pharmacology model for acute viral hepatitis B.

Asin-Prieto E, Parra-Guillen Z, Gomez Mantilla J, Vandenbossche J, Stuyckens K, de Trixhe X Comput Struct Biotechnol J. 2021; 19:4997-5007.

PMID: 34589180 PMC: 8449028. DOI: 10.1016/j.csbj.2021.08.052.


HBV-Specific CD8+ T-Cell Tolerance in the Liver.

Baudi I, Kawashima K, Isogawa M Front Immunol. 2021; 12:721975.

PMID: 34421926 PMC: 8378532. DOI: 10.3389/fimmu.2021.721975.


Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients.

de Almeida Ribeiro C, de Almeida N, Martinelli K, Amendola Pires M, Brandao Mello C, Barros J Virol J. 2021; 18(1):15.

PMID: 33435966 PMC: 7802259. DOI: 10.1186/s12985-021-01487-2.